Nanotechnology‐based drug delivery systems for melanoma antitumoral therapy: a review

RB Rigon, MH Oyafuso, AT Fujimura… - BioMed research …, 2015 - Wiley Online Library
Melanoma (MEL) is a less common type of skin cancer, but it is more aggressive with a high
mortality rate. The World Cancer Research Fund International (GLOBOCAN 2012) estimates …

Options of therapeutics and novel delivery systems of drugs for the treatment of melanoma

H Wang, TT Tran, KT Duong, T Nguyen… - Molecular …, 2022 - ACS Publications
Melanoma is one of the most severe cancerous diseases. The cells employ multiple
signaling pathways, such as ERK, HGF/c-MET, WNT, and COX-2 to cause the cell …

[HTML][HTML] Nanodelivery systems for cutaneous melanoma treatment

I Pereira, C Monteiro, M Pereira-Silva, D Peixoto… - European journal of …, 2023 - Elsevier
Cutaneous melanoma (CM) is a multifactorial disease whose treatment still presents
challenges: the rapid progression to advanced CM, which leads to frequent recurrences …

Nano-drug delivery system targeting tumor microenvironment: a prospective strategy for melanoma treatment

M Xu, S Li - Cancer Letters, 2023 - Elsevier
Melanoma, the most aggressive form of cutaneous malignancy arising from melanocytes, is
frequently characterized by metastasis. Despite considerable progress in melanoma …

Nanomedicine: A pragmatic approach for tackling melanoma skin cancer

VM Prajapat, S Mahajan, PG Paul, M Aalhate… - Journal of Drug Delivery …, 2023 - Elsevier
Melanoma is the most aggressive form of skin cancer and its annual incidence rates are
increasing globally. Though chemotherapy, radiotherapy, immunotherapy and targeted …

Recent advances in targeted nanoparticles drug delivery to melanoma

J Li, Y Wang, R Liang, X An, K Wang, G Shen… - … , Biology and Medicine, 2015 - Elsevier
Melanoma is one of the most aggressive skin cancers, notorious for its high multidrug
resistance and low survival rate. Conventional therapies (eg, dacarbazine, interferon-alpha …

Nanocarrier-based drug delivery for melanoma therapeutics

M Song, C Liu, S Chen, W Zhang - International Journal of Molecular …, 2021 - mdpi.com
Melanoma, as a tumor cell derived from melanocyte transformation, has the characteristics
of malignant proliferation, high metastasis, rapid recurrence, and a low survival rate …

Recent developments in nanomedicine for melanoma treatment

JQ Tang, XY Hou, CS Yang, YX Li, Y Xin… - … journal of cancer, 2017 - Wiley Online Library
Melanoma is a most aggressive skin cancer with limited therapeutic options and its
incidence is increasing rapidly in recent years. The discovery and application of new …

Drug Delivery Systems and Flavonoids: Current Knowledge in Melanoma Treatment and Future Perspectives

C Cunha, AL Daniel-da-Silva, H Oliveira - Micromachines, 2022 - mdpi.com
Melanoma is an aggressive form of skin cancer with a high prevalence in the population. An
early diagnosis is crucial to cure this disease. Still, when this is not possible, combining …

Nanotechnology addressing cutaneous melanoma: The Italian landscape

L Battaglia, A Scomparin, C Dianzani, P Milla… - Pharmaceutics, 2021 - mdpi.com
Cutaneous melanoma is one of the most aggressive solid tumors, with a low survival for the
metastatic stage. Currently, clinical melanoma treatments include surgery, chemotherapy …